SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Up 8.7% - Time to Buy?

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) shot up 8.7% during mid-day trading on Monday . The company traded as high as $3.27 and last traded at $3.25. 159,559 shares changed hands during trading, an increase of 170% from the average session volume of 59,113 shares. The stock had previously closed at $2.99.

SOPHiA GENETICS Price Performance

The stock's fifty day moving average price is $3.01 and its 200-day moving average price is $3.22. The firm has a market cap of $237.42 million, a price-to-earnings ratio of -3.56 and a beta of 1.00. The company has a current ratio of 3.11, a quick ratio of 2.94 and a debt-to-equity ratio of 0.16.

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.05). SOPHiA GENETICS had a negative return on equity of 63.47% and a negative net margin of 98.51%. The company had revenue of $17.78 million for the quarter, compared to analysts' expectations of $16.76 million. As a group, equities research analysts forecast that SOPHiA GENETICS SA will post -0.96 earnings per share for the current fiscal year.

Institutional Investors Weigh In On SOPHiA GENETICS

Several institutional investors have recently modified their holdings of SOPH. Dimensional Fund Advisors LP lifted its position in shares of SOPHiA GENETICS by 23.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 21,619 shares of the company's stock worth $68,000 after purchasing an additional 4,115 shares during the last quarter. Silverberg Bernstein Capital Management LLC lifted its position in shares of SOPHiA GENETICS by 54.4% during the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 34,675 shares of the company's stock worth $115,000 after purchasing an additional 12,211 shares during the last quarter. Ridgewood Investments LLC lifted its position in shares of SOPHiA GENETICS by 1,930.5% during the 1st quarter. Ridgewood Investments LLC now owns 40,610 shares of the company's stock worth $135,000 after purchasing an additional 38,610 shares during the last quarter. Federated Hermes Inc. lifted its position in shares of SOPHiA GENETICS by 40.5% during the 4th quarter. Federated Hermes Inc. now owns 100,000 shares of the company's stock worth $312,000 after purchasing an additional 28,819 shares during the last quarter. Finally, Bank Pictet & Cie Europe AG raised its stake in SOPHiA GENETICS by 14.4% during the 1st quarter. Bank Pictet & Cie Europe AG now owns 255,200 shares of the company's stock worth $847,000 after acquiring an additional 32,200 shares in the last quarter. 31.59% of the stock is owned by hedge funds and other institutional investors.

SOPHiA GENETICS Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.